Hansoh Pharmaceutical Group Co Ltd - Total Other Income Expense Net
Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Total-Other-Income-Expense-Net" stands at 1.16 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.2027 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 0.2027 Billion Hong Kong Dollars.
The 3 year change is 0.7005 Billion Hong Kong Dollars.
The 5 year change is 0.8976 Billion Hong Kong Dollars.
The Serie's change in Hong Kong Dollars from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +1.16 Billion.
The Serie's change in Hong Kong Dollars from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0 Billion.
Total Other Income Expense Net for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
 | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
 | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
 | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
 | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |